Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Musaffe Tuna

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical and Translational Medicine|August 10, 2025
The role of long non-coding RNAs in lung cancer metastasis: Molecular mechanisms, pathogenesis and clinical implicationsMusaffe Tuna, Gordon B Mills, Christopher I Amos
Neoplasia (New York, N.Y.)|October 6, 2023
Common and distinct patterns of acquired uniparental disomy and homozygous deletions between lung squamous cell carcinomas and lung adenocarcinomaMusaffe Tuna, Gordon B Mills, Christopher I Amos
Neoplasia (New York, N.Y.)|November 18, 2019
Genome-Wide Profiling of Acquired Uniparental Disomy Reveals Prognostic Factors in Head and Neck Squamous Cell CarcinomaMusaffe Tuna, Wenbin Liu, Christopher I Amos, et al.
BMC Medical Genomics|December 11, 2012
Soft tissue sarcoma subtypes exhibit distinct patterns of acquired uniparental disomyMusaffe Tuna, Zhenlin Ju, Christopher I Amos, et al.
Breast Cancer Research and Treatment|May 24, 2011
Prognostic value of acquired uniparental disomy (aUPD) in primary breast cancerMusaffe Tuna, Marcel Smid, John W M Martens, et al.
Biochemical and Biophysical Research Communications|July 20, 2002
Downregulation of Wilms' tumor 1 protein inhibits breast cancer proliferationPablo Zapata-Benavides, Musaffe Tuna, Gabriel Lopez-Berestein, et al.
Plos One|December 15, 2010
Association between acquired uniparental disomy and homozygous mutations and HER2/ER/PR status in breast cancerMusaffe Tuna, Marcel Smid, Dakai Zhu, et al.
Molecular Cancer|February 4, 2015
Prognostic relevance of acquired uniparental disomy in serous ovarian cancerMusaffe Tuna, Zhenlin Ju, Marcel Smid, et al.
British Journal of Cancer|November 30, 2019
Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancersMusaffe Tuna, Zhenlin Ju, Kosuke Yoshihara, et al.
Cancer Research|February 20, 2004
Cyclooxygenase-2 is essential for HER2/neu to suppress N- (4-hydroxyphenyl)retinamide apoptotic effects in breast cancer cellsAnn-Marie Simeone, Yu-Jiang Li, Lyle D Broemeling, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical and Translational Medicine|August 10, 2025
The role of long non-coding RNAs in lung cancer metastasis: Molecular mechanisms, pathogenesis and clinical implicationsMusaffe Tuna, Gordon B Mills, Christopher I Amos
Neoplasia (New York, N.Y.)|October 6, 2023
Common and distinct patterns of acquired uniparental disomy and homozygous deletions between lung squamous cell carcinomas and lung adenocarcinomaMusaffe Tuna, Gordon B Mills, Christopher I Amos
Neoplasia (New York, N.Y.)|November 18, 2019
Genome-Wide Profiling of Acquired Uniparental Disomy Reveals Prognostic Factors in Head and Neck Squamous Cell CarcinomaMusaffe Tuna, Wenbin Liu, Christopher I Amos, et al.
BMC Medical Genomics|December 11, 2012
Soft tissue sarcoma subtypes exhibit distinct patterns of acquired uniparental disomyMusaffe Tuna, Zhenlin Ju, Christopher I Amos, et al.
Breast Cancer Research and Treatment|May 24, 2011
Prognostic value of acquired uniparental disomy (aUPD) in primary breast cancerMusaffe Tuna, Marcel Smid, John W M Martens, et al.
Biochemical and Biophysical Research Communications|July 20, 2002
Downregulation of Wilms' tumor 1 protein inhibits breast cancer proliferationPablo Zapata-Benavides, Musaffe Tuna, Gabriel Lopez-Berestein, et al.
Plos One|December 15, 2010
Association between acquired uniparental disomy and homozygous mutations and HER2/ER/PR status in breast cancerMusaffe Tuna, Marcel Smid, Dakai Zhu, et al.
Molecular Cancer|February 4, 2015
Prognostic relevance of acquired uniparental disomy in serous ovarian cancerMusaffe Tuna, Zhenlin Ju, Marcel Smid, et al.
British Journal of Cancer|November 30, 2019
Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancersMusaffe Tuna, Zhenlin Ju, Kosuke Yoshihara, et al.
Cancer Research|February 20, 2004
Cyclooxygenase-2 is essential for HER2/neu to suppress N- (4-hydroxyphenyl)retinamide apoptotic effects in breast cancer cellsAnn-Marie Simeone, Yu-Jiang Li, Lyle D Broemeling, et al.
Pageof 3